The Multidimensional Prognostic Index predicts in-hospital length of stay in older patients: a multicentre prospective study

Age and Ageing
Alberto PilottoFIRI-SIGG Study Group

Abstract

prediction of length of stay (LOS) may be useful to optimise care plans to reduce the negative outcomes related to hospitalisation. to evaluate whether the Multidimensional Prognostic Index (MPI), based on a Comprehensive Geriatric Assessment (CGA), may predict LOS in hospitalised older patients. prospective multicentre cohort study. twenty Geriatrics Units. patients aged 65 and older consecutively admitted to Geriatrics Units. at admission, the CGA-based MPI was calculated by using a validated algorithm that included information on basal and instrumental activities of daily living, cognitive status, nutritional status, the risk of pressures sores, co-morbidity, number of drugs and co-habitation status. According to validated cut-offs, subjects were divided into three groups of risk, i.e. MPI-1 low risk (value ≤0.33), MPI-2 moderate risk (value 0.34-0.66) and MPI-3 severe risk of mortality (value ≥0.67). two thousand and thirty-three patients were included; 1,159 were women (57.0%). Age- and sex-adjusted mean LOS in patients divided according to the MPI grade was MPI-1 = 10.1 (95% CI 8.6-11.8), MPI-2 = 12.47 (95% CI 10.7-14.68) and MPI-3 = 13.41 (95% CI 11.5-15.7) days (P for trend <0.001). The overall accuracy of the MPI to pr...Continue Reading

References

Jan 1, 1970·The Gerontologist·S KatzR C Grotz
May 1, 1968·Journal of the American Geriatrics Society·B S LinnL Gurel
Apr 16, 1998·Journal of Clinical Epidemiology·V S ThomasI McDowell
Aug 9, 2001·Nestlé Nutrition Workshop Series. Clinical & Performance Programme·Y Guigoz, B Vellas
Mar 6, 2003·Clinical Rehabilitation·B S AdityaM Vassallo
Dec 23, 2003·Journal of the American Geriatrics Society·Kenneth H ChuangC Seth Landefeld
Apr 20, 2005·Journal of General Internal Medicine·Mark R CareyR Scott Braithwaite
May 1, 2007·The American Journal of Medicine·Stacie K LevineDavid Meltzer
Nov 14, 2008·Dementia and Geriatric Cognitive Disorders·Ammar NatalwalaReinhard Heun
Apr 8, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alberto PilottoMarilisa Franceschi
Aug 26, 2010·Population Health Management·Nasiya N Ahmed, Shannon E Pearce
Mar 1, 2011·BMJ Quality & Safety·Franka C BakkerMarcel G M Olde Rikkert
Jul 27, 2011·Archives of Internal Medicine·George C M SiontisJohn P A Ioannidis
Oct 27, 2011·JAMA : the Journal of the American Medical Association·Kenneth E CovinskyC Bree Johnston
Jan 12, 2012·JAMA : the Journal of the American Medical Association·Lindsey C YourmanAlexander K Smith
Jan 12, 2012·JAMA : the Journal of the American Medical Association·Thomas M Gill
Jan 18, 2012·BMJ : British Medical Journal·Simon T Adams, Stephen H Leveson
Feb 4, 2012·Age and Ageing·Inderpal SinghRuth E Hubbard
Apr 12, 2012·Archives of Internal Medicine·Alberto PilottoLuigi Ferrucci
Dec 24, 2013·International Journal of Integrated Care·Ian PhilpJudith F Long

❮ Previous
Next ❯

Citations

May 7, 2020·Journal of Medical Economics·Fernando Fuertes-Guiró, Eduardo Viteri Velasco
Oct 11, 2017·Current Opinion in Clinical Nutrition and Metabolic Care·Milta O Little
May 30, 2020·European Geriatric Medicine·Merete GregersenElse Marie Damsgaard
Nov 7, 2019·Journal of Clinical Medicine·Kimberley BryantArduino A Mangoni
Jun 20, 2020·European Geriatric Medicine·Troels K HansenMerete Gregersen
Sep 18, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alberto PilottoLuigi Ferrucci
Nov 2, 2020·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Maya N ElíasZhan Liang
Feb 24, 2021·European Geriatric Medicine·Francesco Mattace-Raso, Alberto Pilotto
Mar 17, 2020·Ageing Research Reviews·Alberto PilottoLuigi Ferrucci
Apr 6, 2021·Aging and Disease·Stefano RizzaMassimo Federici
Jul 27, 2021·Medical Care·Vincent LequertierAntoine Duclos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.